CA2527499C - Foamable pharmaceutical compositions and methods for treating a disorder - Google Patents

Foamable pharmaceutical compositions and methods for treating a disorder Download PDF

Info

Publication number
CA2527499C
CA2527499C CA2527499A CA2527499A CA2527499C CA 2527499 C CA2527499 C CA 2527499C CA 2527499 A CA2527499 A CA 2527499A CA 2527499 A CA2527499 A CA 2527499A CA 2527499 C CA2527499 C CA 2527499C
Authority
CA
Canada
Prior art keywords
acid
pharmaceutically acceptable
pharmaceutical composition
group
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2527499A
Other languages
English (en)
French (fr)
Other versions
CA2527499A1 (en
Inventor
Karl F. Popp
Edward R. Yuhas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stiefel Laboratories Inc
Original Assignee
Stiefel Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33450867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2527499(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stiefel Laboratories Inc filed Critical Stiefel Laboratories Inc
Publication of CA2527499A1 publication Critical patent/CA2527499A1/en
Application granted granted Critical
Publication of CA2527499C publication Critical patent/CA2527499C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
CA2527499A 2003-05-28 2004-05-27 Foamable pharmaceutical compositions and methods for treating a disorder Expired - Fee Related CA2527499C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/445,487 US7186416B2 (en) 2003-05-28 2003-05-28 Foamable pharmaceutical compositions and methods for treating a disorder
US10/445,487 2003-05-28
PCT/US2004/016733 WO2004105702A2 (en) 2003-05-28 2004-05-27 Foamable pharmaceutical compositions and methods for treating a disorder

Publications (2)

Publication Number Publication Date
CA2527499A1 CA2527499A1 (en) 2004-12-09
CA2527499C true CA2527499C (en) 2012-01-24

Family

ID=33450867

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2527499A Expired - Fee Related CA2527499C (en) 2003-05-28 2004-05-27 Foamable pharmaceutical compositions and methods for treating a disorder

Country Status (15)

Country Link
US (2) US7186416B2 (US20070059253A1-20070315-C00017.png)
EP (1) EP1633368B1 (US20070059253A1-20070315-C00017.png)
JP (1) JP4871728B2 (US20070059253A1-20070315-C00017.png)
KR (1) KR101141220B1 (US20070059253A1-20070315-C00017.png)
CN (1) CN1794998A (US20070059253A1-20070315-C00017.png)
AT (1) ATE533493T1 (US20070059253A1-20070315-C00017.png)
AU (1) AU2004242963B2 (US20070059253A1-20070315-C00017.png)
BR (1) BRPI0410721A (US20070059253A1-20070315-C00017.png)
CA (1) CA2527499C (US20070059253A1-20070315-C00017.png)
ES (1) ES2377064T3 (US20070059253A1-20070315-C00017.png)
IL (1) IL172082A0 (US20070059253A1-20070315-C00017.png)
MX (1) MXPA05012842A (US20070059253A1-20070315-C00017.png)
PL (1) PL1633368T3 (US20070059253A1-20070315-C00017.png)
WO (1) WO2004105702A2 (US20070059253A1-20070315-C00017.png)
ZA (1) ZA200510388B (US20070059253A1-20070315-C00017.png)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US6389455B1 (en) * 1998-09-22 2002-05-14 Richard C. Fuisz Method and apparatus for bouncing electronic messages
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US20050036953A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of ammonium lactate
US20050042182A1 (en) * 2003-08-13 2005-02-24 Moshe Arkin Topical compositions of urea
US20050042268A1 (en) * 2003-07-16 2005-02-24 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
PL3428257T3 (pl) 2003-09-29 2023-11-20 Deb Ip Limited Kompozycje żelopodobne i pieniące o dużej zawartości alkoholu
EP1699431B1 (en) 2003-12-12 2015-08-19 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
WO2005115336A2 (en) * 2004-05-15 2005-12-08 Collegium Pharmaceutical, Inc. Sprayable formulations for the treatment of acute inflammatory skin conditions
ATE446412T1 (de) * 2004-07-06 2009-11-15 Int Paper Co Papiersubstrate mit antimikrobieller verbindung sowie herstellungs- und anwendungsverfahren dafür
US20060034779A1 (en) * 2004-08-02 2006-02-16 Agis Industries (1983) Ltd. Foamable compositions containing vitamin D3 analogues, processes for preparing same and methods of treatment utilizng same
US20060057075A1 (en) * 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
US20060137684A1 (en) * 2004-12-01 2006-06-29 Celeste Evans Compositions and methods of treating irritation and kit therefor
DE102004062775A1 (de) 2004-12-21 2006-06-29 Stockhausen Gmbh Alkoholischer Pumpschaum
BRPI0608347A2 (pt) 2005-03-07 2009-12-08 Deb Worldwide Healthcare Inc composição alcoólica espumável, concentrado de composição, composição alcoólica desinfetante espumável, métodos para formar, produzir e dispensar uma espuma, dispensador não pressurizado, e, métodos para usar uma composição alcoólica de espuma para desinfecção pessoal e para produzir e aplicar a uma pele de indivìduo uma composição alcoólica de espuma desinfetante de pele
WO2007054818A2 (en) 2005-05-09 2007-05-18 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
EP1917072B1 (en) * 2005-06-01 2013-02-27 Stiefel Research Australia Pty Ltd Vitamin formulation
US20100154146A1 (en) 2008-07-02 2010-06-24 S.C. Johnson & Son, Inc. Carpet decor and setting solution compositions
US8846154B2 (en) 2005-06-07 2014-09-30 S.C. Johnson & Son, Inc. Carpet décor and setting solution compositions
WO2007099396A2 (en) * 2005-06-07 2007-09-07 Foamix Ltd. Antibiotic kit and composition and uses thereof
US7651990B2 (en) 2005-06-13 2010-01-26 3M Innovative Properties Company Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use
US20070027119A1 (en) * 2005-07-29 2007-02-01 Ahmed Fahim U Antibacterial composition and method of use
US8778369B2 (en) * 2005-07-29 2014-07-15 Delaval Holding Ab Barrier film-forming compositions and methods of use
EP1948130B1 (en) * 2005-10-24 2013-09-11 Precision Dermatology, Inc. Topical pharmaceutical foam composition
EP2010133B1 (en) 2006-03-31 2016-05-04 Stiefel Research Australia Pty Ltd Foamable suspension gel
ES2530390T3 (es) * 2006-07-05 2015-03-02 Foamix Pharmaceuticals Ltd Vehículo espumante de ácido carboxílico y composiciones farmacéuticas del mismo
CA2659095C (en) 2006-07-14 2015-04-28 Stiefel Research Australia Pty Ltd Fatty acid pharmaceutical foam
JP2009543866A (ja) * 2006-07-18 2009-12-10 ウイラ アイピー プロプライエタリー リミテッド 免疫応答修飾製剤
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
GB2443162B (en) * 2006-10-28 2011-02-09 Nupharm Lab Ltd Betamethasone spray
GB2443161B (en) * 2006-10-28 2011-03-23 Nupharm Lab Ltd Clobetasol spray
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
PL1986473T3 (pl) * 2007-04-03 2017-07-31 Tsinghua University Organiczne urządzenie elektroluminescencyjne
FR2915097B1 (fr) * 2007-04-18 2012-09-28 Fabre Pierre Dermo Cosmetique Mousse antifongique a base de ciclopiroxolamine et de pyrithione de zinc et ses applications medicales et cosmetiques.
US20080275113A1 (en) * 2007-05-04 2008-11-06 Thomas Edward Huetter Antimicrobial Compositions, Products, And Methods Of Use
GB0712308D0 (en) * 2007-06-25 2007-08-01 Kind Group Ltd An inhalable composition
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
DE102007039954A1 (de) * 2007-08-23 2009-02-26 Henkel Ag & Co. Kgaa Reduktive Entfärbung keratinhaltiger Fasern
US8802060B2 (en) * 2007-10-01 2014-08-12 Colgate-Palmolive Company Foamable fluoride oral care composition
WO2009084020A2 (en) * 2007-10-18 2009-07-09 Glenmark Pharmaceuticals Limited Topical composition comprising halobetasol and salicylic acid
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
EP2242476A2 (en) * 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20110223216A1 (en) * 2008-11-17 2011-09-15 Wayne State University Nanoparticles and Porous Particles and Methods of Making the Same
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
EP2343300A1 (en) * 2009-12-05 2011-07-13 Cognis IP Management GmbH Anionic isosorbide derivatives and their use (II)
US8802058B2 (en) * 2010-04-19 2014-08-12 Gelmed, Llc Pharmaceutical compositions and methods for administering the same
EP2672968A4 (en) 2010-10-26 2016-07-13 Quinnova Pharmaceuticals Inc ECONAZOL COMPOSITION AND TREATMENT PROCEDURE THEREWITH
EP2632432B1 (en) 2010-10-26 2020-09-30 Paragon Nordic AB Composition and method for treating wounds
IT1402786B1 (it) * 2010-11-19 2013-09-18 Fidia Farmaceutici Composizioni farmaceutiche ad attivita' antibatterica e cicatrizzante
US9089129B2 (en) 2011-10-07 2015-07-28 American Sterilizer Company Non-aerosol foaming alcohol hand sanitizer
WO2013080043A1 (en) * 2011-11-30 2013-06-06 Basf Se Composition for dissolving and/or inhibiting deposition of scale on a surface of a system
CN102641283B (zh) * 2012-04-07 2013-05-08 张红 一种治疗头屑的药物及其制备方法
CN104703585A (zh) 2012-10-09 2015-06-10 宝洁公司 鉴定协同化妆品组合的方法
CN104704362B (zh) 2012-10-09 2018-08-28 宝洁公司 鉴定或评估有益活性物质的方法以及包含其的组合物
US8962028B2 (en) 2012-10-18 2015-02-24 MiCal Pharmaceuticals LLC—H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limited Liability Company Topical steroid composition and method
EP2938327B1 (en) 2012-12-26 2017-12-06 Otic Pharma Ltd. Foamable otic pharmaceutical compositions
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin
US10111956B2 (en) 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions
US11135297B2 (en) 2013-07-11 2021-10-05 Pola Pharma Inc. External-use composition producing foamed state upon use
CN104032590A (zh) * 2014-05-14 2014-09-10 江苏金秋弹性织物有限公司 一种活性炭-纳米银协同抗菌织带的染色加工工艺
JP6696767B2 (ja) * 2014-12-24 2020-05-20 株式会社ポーラファルマ スクリーンフォーマー用の外用組成物
FR3041538B1 (fr) * 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
AU2016372789B2 (en) * 2015-12-15 2021-12-16 Mayne Pharma Llc Halobetasol foam composition and method of use thereof
CN105486778B (zh) * 2016-01-25 2017-11-03 齐炼文 诊断区分稳定型心绞痛和急性冠脉综合征的代谢标志物
BR112018071523B1 (pt) 2016-04-20 2022-11-01 S.C. Johnson & Son, Inc Composição antimicrobiana aquosa
BR112018073097B1 (pt) 2016-05-11 2022-05-17 Bayer Healthcare Llc Formulação espumante, métodos para fabricar e usar a mesma, e, formulação
WO2017197196A1 (en) 2016-05-11 2017-11-16 Bayer Healthcare Llc Whipped gel formulations
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
MX2019013454A (es) 2017-05-11 2020-08-03 Beiersdorf Ag Formulaciones de gel.
JP6997222B2 (ja) 2017-06-23 2022-01-17 ザ プロクター アンド ギャンブル カンパニー 皮膚の外観を改善するための組成物及び方法
JP2021530447A (ja) 2018-07-03 2021-11-11 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company 皮膚状態の治療方法
WO2020044223A1 (en) * 2018-08-28 2020-03-05 Glenmark Pharmaceuticals Limited Container system and pharmaceutical foam composition comprising betamethasone
EP4127645A1 (en) 2020-03-24 2023-02-08 The Procter & Gamble Company Methods for testing skin samples
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
EP4157206A1 (en) 2020-06-01 2023-04-05 The Procter & Gamble Company Method of improving penetration of a vitamin b3 compound into skin

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4838286A (US20070059253A1-20070315-C00017.png) * 1971-09-18 1973-06-05
US4018918A (en) 1975-05-20 1977-04-19 The Upjohn Company Topical clindamycin preparations
US4141472A (en) * 1976-07-19 1979-02-27 Spitzer Joseph G Aerosol container with gas-permeable membrane
US4141417A (en) 1977-09-09 1979-02-27 Institute Of Gas Technology Enhanced oil recovery
US4420484A (en) 1979-08-13 1983-12-13 Sterling Drug Inc. Basic amino or ammonium antimicrobial agent-polyethylene glycol ester surfactant-betaine and/or amine oxide surfactant compositions and method of use therof
WO1985001876A1 (en) 1983-10-24 1985-05-09 Lockley Services Pty. Ltd. Foamable biocide composition
WO1986000196A1 (en) 1984-06-21 1986-01-16 Soltec Research Pty. Ltd. Aerosol product
US5002680A (en) 1985-03-01 1991-03-26 The Procter & Gamble Company Mild skin cleansing aerosol mousse with skin feel and moisturization benefits
US4806262A (en) 1985-08-14 1989-02-21 The Procter & Gamble Company Nonlathering cleansing mousse with skin conditioning benefits
US5446028A (en) * 1985-12-12 1995-08-29 Dermik Laboratories, Inc. Anti-acne method and composition
JPS62273912A (ja) * 1986-05-21 1987-11-28 Kao Corp 人体塗布用エアゾ−ル剤
US5385938B1 (en) 1986-12-23 1997-07-15 Tristrata Inc Method of using glycolic acid for treating wrinkles
US4882182A (en) 1987-01-08 1989-11-21 Soltec Research Pty. Ltd. Aerosol product
US4847068A (en) 1987-08-06 1989-07-11 Johnson & Johnson Consumer Products, Inc. Skin care compositions
US4885354A (en) 1987-10-29 1989-12-05 Ciba-Geigy Corporation Epoxy resin compositions
US5143717A (en) 1987-12-30 1992-09-01 Code Blue Medical Corporation Burn foam and delivery system
AU619256B2 (en) 1988-03-03 1992-01-23 Connetics Australia Pty Ltd Acne treatment
US5110809A (en) 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
ES2103737T3 (es) 1989-03-17 1997-10-01 Taisho Pharmaceutical Co Ltd Preparacion de aerosol para uso externo.
ATE124860T1 (de) * 1989-07-28 1995-07-15 Hisamitsu Pharmaceutical Co Schaumaerosolzusammensetzung.
IL95952A0 (en) 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
US5935554A (en) 1990-09-03 1999-08-10 Soltec Research Pty. Ltd. Concentrated aerosol space spray that is not an emulsion
JP3140460B2 (ja) 1990-09-03 2001-03-05 ソルテック リサーチ プロプライアタリィ リミティド 濃縮したエーロゾルスペーススプレー
US5167950A (en) 1991-03-28 1992-12-01 S. C. Johnson & Son High alcohol content aerosol antimicrobial mousse
FR2677369B1 (fr) 1991-06-05 1994-09-16 Promotion Rech Innovation Tec Mousse aerosol.
DE4129756C2 (de) 1991-09-04 1995-06-29 Mannesmann Ag Metallurgisches Gefäß für eine Gleichstromlichtbogeneinrichtung
GB2260079B (en) * 1991-10-01 1995-08-09 American Cyanamid Co Pharmaceutical composition containing felbinac
US5211317A (en) 1992-06-18 1993-05-18 Diamond George Bernard Low pressure non-barrier type, valved dispensing can
ZA94170B (en) 1993-01-20 1995-03-15 Soltec Res Pty Ltd Ectoparasiticidal formulation
US5570296A (en) 1994-03-30 1996-10-29 Apple Computer, Inc. System and method for synchronized presentation of video and audio signals
US5679324A (en) 1994-07-08 1997-10-21 The Procter & Gamble Co. Aerosol foamable fragrance composition
US5776430A (en) 1994-11-01 1998-07-07 Calgon Vestal, Inc. Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol
JPH08175982A (ja) * 1994-12-21 1996-07-09 Lederle Japan Ltd ４−ビフェニリル酢酸組成液
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
US5783202A (en) 1995-03-14 1998-07-21 Soltec Research Pty. Ltd. Pediculicidal mousse composition for killing head lice
DE69622269T2 (de) 1995-04-14 2003-03-06 Smithkline Beecham Corp Dosierinhalator für fluticasonepropionat
EP0738510A3 (fr) 1995-04-20 2005-12-21 L'oreal Utilisation d'un inhibiteur d'HMG-coenzyme A-reductase pour lutter contre le vieillissement de la peau et pour traiter l'acné. Composition comprenant au moins un inhibiteur HMG-coenzyme A reductase et au moins un actif possédant des propriétes desquamantes
FR2740685B1 (fr) 1995-11-08 1998-01-23 Pf Medicament Composition pharmaceutique topique moussante pour le traitement des dermatoses, induites par pityrosporum ovale
US5788155A (en) 1996-06-28 1998-08-04 S. C. Johnson & Son, Inc. Air freshener dispenser device with dual cartridge capacity
DE19631221C2 (de) 1996-08-02 1999-07-01 Beiersdorf Ag Schaumförmige Lichtschutzzubereitungen mit einem Gehalt an wasserlöslichen Lichtschutzfiltersubstanzen und grenzflächenaktiven Substanzen
US5863560A (en) 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
AUPO379596A0 (en) 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
AUPO688997A0 (en) 1997-05-20 1997-06-12 Soltec Research Pty Ltd Sunscreen composition
AU729680B2 (en) 1997-06-13 2001-02-08 Taisho Pharmaceutical Co., Ltd. Aerosol preparation
GB2327344A (en) 1997-07-18 1999-01-27 Ninh Thuy On Pharmaceutical compositions containing phenytoin and either an azole anti-fungal/anti-bacterial agent and/or a silver salt for topical application
US5965500A (en) 1997-07-24 1999-10-12 Levers Brothers Company, Division Of Conopco, Inc. Stable liquid composition comprising high levels of emollients
AUPO983897A0 (en) 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
ES2193514T3 (es) 1998-02-02 2003-11-01 Boehringer Ingelheim Vetmed Utilizacion de combinaciones de sustancias activas a base de antibioticos y de estractos vegetales que contienen terpenos en la medicina veterinaria.
US6030931A (en) 1998-02-03 2000-02-29 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Foaming cleansing skin product
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
AUPP583198A0 (en) 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6264964B1 (en) 1999-04-14 2001-07-24 Conopco, Inc. Foaming cosmetic products
AUPQ002999A0 (en) 1999-04-29 1999-05-20 Soltec Research Pty Ltd Non-aqueous shampoo composition
US6547063B1 (en) 2000-10-10 2003-04-15 The Procter & Gamble Company Article for the delivery of foam products
FR2820038B1 (fr) * 2001-01-29 2004-07-02 Dermaconcept Jmc Composition dermatologique a usage veterinaire comprenant une base sphingoide
HU0104790D0 (en) 2001-11-08 2002-01-28 Human Rt Pharmaceutical combinations for topical application
JP4828404B2 (ja) 2003-01-24 2011-11-30 ステフェル リサーチ オーストラリア プロプライエタリー リミティッド リン酸クリンダマイシン発泡体
US8312963B2 (en) * 2008-02-14 2012-11-20 Nagoya Oilchemical Co., Ltd Sound absorbing skin material and sound absorbing material utilizing the same

Also Published As

Publication number Publication date
CN1794998A (zh) 2006-06-28
JP2007500235A (ja) 2007-01-11
ZA200510388B (en) 2006-12-27
KR101141220B1 (ko) 2012-05-07
CA2527499A1 (en) 2004-12-09
EP1633368A2 (en) 2006-03-15
ES2377064T3 (es) 2012-03-22
ATE533493T1 (de) 2011-12-15
WO2004105702A3 (en) 2005-05-06
AU2004242963B2 (en) 2009-05-28
US7186416B2 (en) 2007-03-06
US20040241099A1 (en) 2004-12-02
WO2004105702A2 (en) 2004-12-09
MXPA05012842A (es) 2006-05-17
EP1633368A4 (en) 2007-03-14
US7829107B2 (en) 2010-11-09
BRPI0410721A (pt) 2006-06-20
EP1633368B1 (en) 2011-11-16
KR20060023972A (ko) 2006-03-15
IL172082A0 (en) 2009-02-11
US20070059253A1 (en) 2007-03-15
JP4871728B2 (ja) 2012-02-08
AU2004242963A1 (en) 2004-12-09
PL1633368T3 (pl) 2012-04-30

Similar Documents

Publication Publication Date Title
CA2527499C (en) Foamable pharmaceutical compositions and methods for treating a disorder
US11433025B2 (en) Oil foamable carriers and formulations
EP2422768B1 (en) Penetrating pharmaceutical foam
US20170119665A1 (en) Penetrating pharmaceutical foam
US20140086848A1 (en) Foamable compositions and methods for disorders of the skin or mucosal surfaces
JPH1112136A (ja) ミノキシジル配合エアゾール剤
BR112018073084B1 (pt) Formulação, e, embalagem pressurizada
JP4450545B2 (ja) エアゾール製剤
JP5276781B2 (ja) エアゾール組成物
US11427741B2 (en) Cryogenic, kinetically active formulations and systems for their dispensing
JPH04264186A (ja) エヤゾール組成物
JPH0730310B2 (ja) 無水泡沫剤

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20190527